T1	Participants 114 136	stage III colon cancer
T2	Participants 492 571	patients with stage III colon cancer who enrolled in a phase III clinical trial
T3	Participants 1340 1423	G-allele carriers were significantly more frequent in Caucasians versus other races
T4	Participants 1776 1789	colon cancers
T5	Participants 1892 1921	atients with stage III tumors
